retatrutide clinical trial safety trials Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease retatrutide clinical trials safety retatrutide – retatrutide clinical trial status TRIUMPH-3

GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study

While prescription GLP-1 drugs offer the most dramatic results and stimulant-based products deliver quick bursts of energy, ColonBroom fills the middle ground: accessible, safe for long-term use, and focused on gradual appetite control

The lidocaine in the formula helps to minimize discomfort, making the procedure more comfortable

Tolerance differs from person to person

Karl Nadolsky, DO, Assistant Clinical Professor at Michigan State University College of Human Medicine and Director of the Endocrine Clinic at the Gym, says there is a paradigm shift toward the quality and kind of weight loss versus a focus on the amount of weight lost

10.2337/db10-0098